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Abstract 
Background: Hepatocarcinogenesis is a multistep process characterized in patients with chronic liver diseases by a 
spectrum of hepatic nodules that mark the progression from regenerative nodules to dysplastic lesions followed by 
hepatocellular carcinoma (HCC). The differential diagnosis between precancerous dysplastic nodules and early HCC 
still represents a challenge for both radiologists and pathologists. We addressed the potential of Fourier transform-
infrared (FTIR) microspectroscopy for grading cirrhotic nodules on frozen tissue sections.
Methods: The study was focused on 39 surgical specimens including normal livers (n = 11), dysplastic nodules 
(n = 6), early HCC (n = 1), progressed HCC on alcoholic cirrhosis (n = 10) or hepatitis C virus cirrhosis (n = 11). The use 
of the bright infrared source emitted by the synchrotron radiation allowed investigating the biochemical composi-
tion at the cellular level. Chemical mapping on whole tissue sections was further performed using a FTIR microscope 
equipped with a laboratory-based infrared source. The variance was addressed by principal component analysis.
Results: Profound alterations of the biochemical composition of the pathological liver were demonstrated by FTIR 
microspectroscopy. Indeed, dramatic changes were observed in lipids, proteins and sugars highlighting the metabolic 
reprogramming in carcinogenesis. Quantifiable spectral markers were characterized by calculating ratios of areas 
under specific bands along the infrared spectrum. These markers allowed the discrimination of cirrhotic nodules, dys-
plastic lesions and HCC. Finally, the spectral markers can be measured using a laboratory FTIR microscope that may be 
easily implemented at the hospital.
Conclusion: Metabolic reprogramming in liver carcinogenesis can constitute a signature easily detectable using FTIR 
microspectroscopy for the diagnosis of precancerous and cancerous lesions.
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Background
Hepatocellular carcinoma (HCC) is the sixth most com-
mon neoplasm and the second cause of cancer death 
worldwide [1, 2]. In Western countries, HCC develops in 
most cases within an established background of cirrho-
sis related to various etiologies including hepatitis virus 
infection, high alcohol intake or metabolic diseases. The 
systematic surveillance of cirrhotic patients by ultra-
sound aims to the identification of HCC at a very early 
stage (<2  cm) with the highest probability of long-term 
cure. It may also lead to the detection of hepatocellu-
lar nodules of uncertain diagnosis. Proper definition of 
these nodules as pre-neoplastic lesions or early HCC has 
critical implications. Dysplastic lesions should be only 
followed by regular imaging and only HCC diagnosis ena-
bles the application of potentially curative procedures—
albeit expensive—such as resection, transplantation and 
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percutaneous ablation. Thus, there is an urgent need to 
identify better tools to characterize these lesions.
Hepatocarcinogenesis is a multistep process that is 
characterized in most cirrhotic livers by the progression 
from hyperplastic regenerative nodules to low grade dys-
plastic nodules (LGDN), high grade dysplastic nodules 
(HGDN) and finally small HCC (less than 2  cm) which 
corresponds either to vaguely nodular well differenti-
ated HCC (WDHCC) so called early HCC or to distinctly 
nodular moderately differentiated hepatocellular carcino-
mas [3–9]. The differential diagnosis between high-grade 
dysplastic nodules (HGDN) and WDHCC still represents 
a challenge even for experienced pathologists, especially 
on biopsy specimens as the only discriminative feature is 
the presence of focal stromal invasion [5].
Promising results have been reported on gene signa-
tures allowing molecular demarcations between low-
grade dysplastic nodules, high-grade dysplastic nodules, 
and early HCC in both Asian and Western patients [10, 
11]. However, the clinical use of gene signatures may 
face some limitations (too high level of technicity, time-
consuming and expensive) and thus are not employed in 
routine at the hospital. The morphological criteria which 
define early HCC such as cell density, thickness of liver 
cell plates, presence of pseudoglands, loss of reticulin, 
CD34 expression, small cell dysplasia and stromal inva-
sion [3, 6] are also present in high grade dysplastic nod-
ules without clearcut frontier between both lesions. As a 
consequence, the discrepancies for the early HCC diag-
nosis are frequent even between expert pathologists [12]. 
Additional immunohistochemical markers as glypican-3 
(GPC3), heat-shock protein 70 (HSP70) and glutamine 
synthetase (GS) were reported to better characterize 
early HCC [13, 14]. However a recent prospective study 
has shown that the use of the antibody panel (GPC3, GS 
and HSP70) only slightly increases the diagnosis accuracy 
in an expert setting. Indeed, the sensitivity and specificity 
for early HCC diagnosis were not highly accurate for each 
marker (GPC3: 57.5 and 95 %; HSP70: 57.5 and 85 %; GS: 
50 and 90 %) as well as in combination (GPC3 + HSP70: 
40 and 100 %; GPC3 + GS: 35 and 100 %; HSP70 + GS: 
35 and 100 %; GPC3 + HSP70 + GS: 25 and 100 %) [15]. 
Thus, specific biomarkers of early stages of HCC are still 
lacking [15].
Infrared spectroscopy is based on the determination 
of absorption of infrared light due to resonance with 
vibrational motions of functional molecular groups. Bio-
logical tissue is essentially made up of lipids, proteins 
and carbohydrates, all of which have specific absorption 
bands in the infrared frequency domain. Thus, infra-
red spectroscopy is a very valuable tool for biochemical 
investigations. Fourier Transform Infrared (FTIR) micro-
spectroscopy combines IR spectroscopy and microscopy 
for determining the chemical composition in small sam-
ple area. The increase of spectral quality and spatial reso-
lution was achieved using a bright infrared source, as that 
produced by synchrotron radiation, thus allowing analy-
sis at the cellular and sub-cellular levels [16–18]. FTIR 
microspectroscopy has been used to investigate subtle 
changes associated with various biological processes and 
discriminate between malignant and non-malignant cells 
in several different tissues, such as cervix, breast, colon 
and prostate. This method was capable of identifying a 
valid biochemical difference between healthy tissues and 
more or less aggressive tumors [19–25].
The development of cirrhosis and HCC from chronic 
liver diseases induces a series of changes in the chemical 
composition of cells and tissues. We have shown previ-
ously the capability of FTIR microspectroscopy to inves-
tigate the chemical composition of liver lesions such as 
steatosis or cirrhosis [26–29]. The diagnostic potential of 
FTIR microspectroscopy has been recently highlighted 
by the quantitative assessment of liver steatosis on tissue 
sections [30]. In this report, we demonstrated that FTIR 
microspectroscopy exhibits the potentiality to detect the 
chemical changes occurring in hepatocarcinogenesis and 
to discriminate benign cirrhotic nodules, premalignant 
(dysplastic) and malignant (cancerous) nodules in cir-
rhotic liver.
Methods
Samples and tissue sections
Tissue samples from 11 surgical liver specimens of nor-
mal liver obtained from patients with benign liver tumor 
or from patients with metastases of colorectal cancer, 
21 native livers of patients with hepatocellular carci-
noma developed on alcoholic (n  =  10) or hepatitis C 
virus (HCV) (n  =  11) cirrhosis and 7 additional native 
livers of patients with hepatitis B virus (HBV) (n  =  1), 
HCV (n = 3) or alcoholic (n = 3) cirrhosis and hepato-
cellular nodules initially diagnosed as dysplastic nodules 
(Table  1) were obtained from the Centre de Ressources 
Biologiques (CRB) Paris-Sud (AFNOR#2011/39938, 
Paris-Sud University, France). Three among the seven 
additional native livers also disclosed a progressed HCC 
in addition with the dysplastic nodule. For cirrhotic 
patients, investigations were performed on non-tumor 
cirrhotic liver and on every type of hepatocellular nodule. 
The institutional review board approved the study and 
written informed consent was obtained from all patients. 
Access to this material was in agreement with French 
ethical laws.
Samples were all obtained at the time of surgery. Sam-
ples from normal liver, non-tumor cirrhotic parenchyma 
and hepatocellular nodules in cirrhotic livers were split 
into two pieces: one immediately snap frozen in liquid 
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nitrogen and stored at −80 °C until use; the second was 
fixed in formalin and embedded in paraffin wax for path-
ological assessment by expert pathologist.
Serial sections were cut from frozen specimens with 
5  µm thickness at −20  °C with a CM3050-S cryostat 
(Leica Microsystèmes SAS, France) and alternately 
deposited on glass slide for histological control or on a 
gold coated sample holder MirrIR (Tientascience, Indian-
apolis, IN) for FTIR microspectroscopy [26–31]. Sections 
for microspectroscopy were placed in a desiccator loaded 
with silica gel for at least 4 days. They were dried in the 
dark environment at room temperature. After drying, 
Table 1 History of patients and origin of samples
FNH focal nodular hyperplasia, CRC colorectal cancer, GC gallbladder cancer, HBV hepatitis B virus, HCV hepatitis C virus, HCC progressed HCC, LGDN low grade 
dysplastic nodule, HGDN high grade dysplastic nodule
Patient Gender Age (year) Tissue samples Associated diagnosis SR-FTIR Internal source
1 F 31 Normal liver FNH + +
2 F 26 Normal liver FNH + +
3 F 25 Normal liver FNH + +
4 M 59 Normal liver Metastasis (GC) + +
5 F 37 Normal liver FNH + −
6 M 50 Normal liver Metastasis (CRC) − +
7 F 26 Normal liver FNH − +
8 F 39 Normal liver Hepatic adenoma − +
9 F 54 Normal liver FNH − +
10 F 30 Normal liver FNH − +
11 M 61 Normal liver Metastasis (CRC) − +
12 M 62 Cirrhosis/HCC Alcohol + +
13 M 60 Cirrhosis/HCC Alcohol + +
14 M 58 Cirrhosis/HCC Alcohol + +
15 M 49 Cirrhosis/HCC Alcohol − +
16 M 84 Cirrhosis/HCC Alcohol − +
17 M 57 Cirrhosis/HCC Alcohol − +
18 M 60 Cirrhosis/HCC Alcohol − +
19 M 61 Cirrhosis/HCC Alcohol − +
20 M 61 Cirrhosis/HCC Alcohol − +
21 M 67 Cirrhosis/HCC Alcohol − +
22 M 49 Cirrhosis/HCC HCV − +
23 F 80 Cirrhosis/HCC HCV − +
24 F 66 Cirrhosis/HCC HCV − +
25 F 77 Cirrhosis/HCC HCV − +
26 F 56 Cirrhosis/HCC HCV − +
27 F 59 Cirrhosis/HCC HCV − +
28 M 68 Cirrhosis/HCC HCV − +
29 M 61 Cirrhosis/HCC HCV − +
30 M 71 Cirrhosis/HCC HCV − +
31 M 65 Cirrhosis/HCC HCV − +
32 F 66 Cirrhosis/HCC HCV − +
33 F 58 Cirrhosis/HGDN with nodules of HCC HCV − +
34 M 59 Cirrhosis/HGDN Alcohol − +
35 M 48 Cirrhosis/Early HCC HCV − +
36 M 55 Cirrhosis/HGDN HBV − +
37 M 59 Cirrhosis/HGDN/HCC Alcohol + +
38 M 66 Cirrhosis/LGDN/HCC Alcohol − +
39 M 53 Cirrhosis/HGDN/HCC HCV − +
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samples were stored in a N2 atmosphere until used. Sec-
tions for histology were stained with hematoxylin, eosin 
and safran (HES).
Dysplastic nodules were systematically reviewed by 
two pathologists (Dr. Natalia Olaya and Pr. Catherine 
Guettier) on paraffin sections stained with HES and with 
Gordon-Sweet silver impregnation. Additional immu-
nostaining was performed on deparaffinized sections 
after antigenic restoration by heating in citrate buffer pH6 
with antibodies directed against CD34 (clone QBEnd-10, 
Dako), glypican-3 (GPC-3), (clone 1G12, Zytomed), glu-
tamine synthetase (GS) (clone 6, Biosciences) and HSP70 
(clone 2A4, Abcam) using a Bond Max automate based 
on a labeled streptavidin–biotin (LSAB) method. Nod-
ules were diagnosed as low-grade dysplastic nodules, 
high-grade dysplastic nodules or well differentiated hepa-
tocellular carcinoma so called early carcinoma according 
to the International Consensus Group for International 
neoplasia criteria [5] (Table 2).
FTIR microspectroscopy
FTIR microspectroscopy was performed in transflection 
mode. In transflection mode, the sample is placed on an 
inexpensive IR-reflecting surface and measurements are 
generated by a beam passing through the sample and 
reflecting back from the surface (i.e. the reflective sur-
face) through the sample [31].
Synchrotron infrared microspectroscopy was per-
formed at the SMIS beamline at the SOLEIL Synchro-
tron Radiation Facility (Saint-Aubin, France) operating at 
2.75 GeV with a current of 400 mA delivered in Top-Up 
mode. Infrared photons were emitted by the electrons 
deflected from a bending magnet in the storage ring. The 
infrared photon source was coupled to a Thermo Fis-
cher NEXUS FTIR spectrometer Nicolet 5700. Attached 
to the spectrometer was a microscope CONTINUUM 
XL (Thermo Scientific, CA, USA). The detector of the 
infrared microscope was a liquid nitrogen cooled mer-
cury cadmium telluride (MCT-A) detector (of 50  µm 
in size). The microscope operated in confocal mode, 
using a 32×  infinity corrected Schwarzschild objective 
(NA = 0.65) and a matching 32× condenser. All spectra 
were obtained using a double path single masking aper-
ture (confocal arrangement) size set to 10 µm × 10 µm. 
The spectra were collected in the 4000–800  cm−1 mid-
infrared range at a resolution of 4 or 8 cm−1 with 16–50 
co-added scans. Each spectrum was recorded in approxi-
mately 10–25  s. Details of the experimental procedure 
have been already described [26–29]. Infrared micro-
spectroscopy was also performed on iN10MX micro-
scope equipped with an internal thermal source (Thermo 
Scientific) for recording large maps. All spectra were col-
lected by ultra-fast mode using 50 µm × 50 µm aperture. 
The spectra were collected in the 4000–800  cm−1 mid-
infrared range at a resolution of 16 cm−1 with 1 spectrum 
per pixel [28]. Infrared spectra were acquired at least on 
two maps of 500 pixels for each tissue section. IR spec-
tra were collected only on the hepatocellular parenchyma 
avoiding the portal tracts in normal liver and the fibrous 
septa in cirrhotic liver.
Data preprocessing and statistical analysis
The infrared images were incorporated into OMNIC 
version 7.2 (Thermo Scientific) software in order to 
extract the spectral data that were deemed suitable for 
further analysis. The spectra first underwent a qual-
ity test whereby spectra that had maximum absorbance 
values outside the range 0.4–1.0 were rejected. This was 
to ensure that measurements with a good signal to noise 
ratio and spectral signal within a Beer-Lambert law range 
were used in further steps. Similarly, the spectra, which 
showed the presence of Mie scattering, were rejected. 
After the quality test, for each patient we obtained 
at least 200 spectra measured by synchrotron source 
and 800 spectra when the globar source was used. The 
spectra, which passed the quality test, underwent fur-
ther preprocessing in The Unscrambler X version 10.1 
(CAMO Process AS, Norway) software package. They 
were converted to their first derivatives with a Savitsky-
Golay algorithm, followed by range normalization. The 
spectral data were mean-centered and then statistically 
analyzed by principal component analysis (PCA). The 
spectral intervals considered to discriminate IR spectra 
were selected by unsupervised criteria. The mean spectra 
were baseline corrected and normalized using the unit 
vector normalization in The Unsrambler X. The integrals 
reflecting peak areas were considered to calculate the 
ratio values. The t test was calculated using the Micro-
cal Origin, version 8.0 program (Microcal Software Inc., 
Northampton, MA).
Results
Discriminating cirrhosis and hepatocellular carcinoma 
by synchrotron radiation infrared microspectroscopy
Cirrhosis and hepatocellular carcinoma (HCC) were 
investigated by Fourier transform infrared microspec-
troscopy using synchrotron radiation (SR-FTIR). The 
high resolution obtained using synchrotron radiation 
allows addressing the chemical composition at the cel-
lular level (Fig. 1) and thus leads to investigate in depth 
the variance in tissues. Spectra were acquired on frozen 
tissue sections from normal livers, cirrhotic livers and 
their corresponding HCC (Table 1), and the variance was 
addressed by principal component analysis (PCA). This 
unsupervised multivariate statistical method decomposes 
the data into a weighted sum of uncorrelated principal 
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components (PCs). In the data set coordinate system, the 
first PC becomes the first axis of a new coordinate system 
and explains the highest variance of the data set. The sec-
ond PC becomes the second axis, orthogonal to the first 
one, and explains the next highest variance of the data 
set, and so on [32, 33].
The study was first focused on lipids (2800–3000 cm−1) 
in IR spectra. Discrimination between the IR spectra of 
normal liver (control group) and pathological tissues (cir-
rhosis and HCC) was observed (Fig. 2a, b). The average 
spectrum corresponding to the normal tissue, cirrhosis 
or HCC lead to observe a lower intensity of the peaks 
corresponding to CH3 motions (2872 and 2957  cm−1) 
in the pathological tissues whereas the peaks attributed 
to CH2 vibrations (2851 and 2920  cm−1) were higher 
(Fig. 2c; Additional file 1: Table S1). The value of the ratio 
CH2/CH3 was calculated and plotted demonstrating the 
significant increase of CH2 relative intensity in cirrho-
sis and HCC as compared to the healthy tissue (Fig. 2d). 
These results suggested that the development of cirrho-
sis is accompanied by important changes of lipids with 
longer carbon chains.
The IR frequency domain 1475–1710  cm−1 attributed 
to the content in proteins was also investigated. PCA 
discriminated the vibrational signatures of normal and 
pathological liver (Fig.  3a, b). The average spectrum of 
each group revealed a gradual downward frequency shift 
of the bands Amide I and Amide II between normal liver, 
cirrhosis and HCC (Fig. 3c). This shift was quantified by 
displaying the area ratio (1700–1660/1660–1610) demon-
strating a significant variation between normal liver and 
cirrhosis which was accentuated in HCC (Fig. 3d). These 
observations suggest that changes occur in the proteome 
in the course of cirrhosis and hepatocarcinogenesis.
Investigations were also performed on the frequency 
domain 950–1480  cm−1. This domain is characterized 
by bands overlapping lipids, proteins, nucleic acids and 
carbohydrates (Additional file 1: Table S1). PCA on nor-
mal liver, cirrhosis or HCC displayed distinct groups 
which also discriminated normal and pathological liver 
tissues (Fig.  4a). Interestingly, cirrhosis and HCC were 
identified by PCA on infrared spectra. Indeed, 27  % of 
the variance was observed on the first component (PC1) 
allowing a valuable separation of the two pathological 
statuses (Fig. 4b). According with these observations, the 
average spectra of the frequency domain 950–1480 cm−1 
exhibited major variations in the intensity and frequency 
of several peaks (Fig.  4c). These results manifested the 
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Fig. 1 SR-FTIR analysis on cirrhotic liver. Tissue sections of 5 µm thickness were performed from cirrhosis and stained with HES (hematoxylin, eosin 
and safran). Cirrhosis exhibiting nodules surrounded by fibrosis are shown at ×40 magnification (upper left). Synchrotron-FTIR was performed on 
tissue section of cirrhosis at the resolution 10 µm × 10 µm (black square on upper right). The infrared spectrum is shown
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marked chemical changes occurring during carcinogen-
esis and supported the potential of infrared spectroscopy 
for discriminating cirrhotic and cancerous hepatocytes.
Discriminating dysplastic nodules from cirrhosis 
and hepatocellular carcinoma by synchrotron radiation 
infrared microspectroscopy
The possibility to distinguish HCC from cirrhosis by SR-
FTIR led to investigate the potential of infrared spec-
troscopy for discriminating early stages of cancer. Thus, 
the study was focused on dysplastic lesions, which cor-
respond to precancerous stages. Acquisitions of IR spec-
tra were performed on frozen tissue sections of cirrhotic 
nodules, high-grade dysplastic nodule and hepatocellu-
lar carcinoma from the same patient with HCV cirrhosis 
(patient #37, Tables  1, 2). Principal component analysis 
was performed on the frequency domains correspond-
ing to lipids, proteins and sugars (Fig.  5) as described 
above. On the fingerprinting region 950–1480  cm−1, 
PCA was performed on three distinct frequency domains: 
1360–1480, 1180–1360 and 950–1180  cm−1. In all fre-
quency domains, a clear discrimination of IR spectra was 
observed between cirrhosis and HCC originating from the 
same patient. Interestingly, the spectra acquired on high-
grade dysplastic nodule behaved intermediately between 
cirrhosis and HCC or partially superimposed with those 
from HCC (Fig. 5). Moreover, the PCA and average spec-
tra obtained on the frequency domains 1360–1480 and 
950–1180  cm−1 appeared as the most discriminative for 
cirrhosis, dysplastic nodule and HCC (Fig. 5). These fre-
quency domains correspond respectively to overlapped 
vibrations from lipids and proteins, and to sugars (Addi-
tional file 1: Table S1). Furthermore, the most important 
variation in the sugars was observed on the bands 950–
1050 cm−1 attributed to the glycogen content suggesting 
important changes in such a component in the tumor 
progression. These results demonstrated that infrared 
spectroscopy allows grading hepatocellular nodules in cir-
rhotic liver thus leading to discriminate dysplastic lesions.
From the synchrotron to a laboratory-based infrared 
source
The potential of synchrotron radiation infrared micro-
spectroscopy for discriminating dysplastic lesions 
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represents a great interest for the diagnosis of precan-
cerous lesions on patients with cirrhosis. However, the 
limited access to such a large-scale facility prohibits an 
extensive use of the technique as a routine diagnostic 
tool for hospital purpose. We have addressed this issue 
and used a laboratory-based infrared source on a micro-
scope that can be easily positioned in a clinical environ-
ment. Although such an instrument exhibits a poorer 
lateral resolution as compared to the bright synchrotron 
radiation, the device allows rapid acquisition of spectra 
on the whole tissue section leading to a global picture of 
the composition of the tissue (Fig. 6a–e). The potential of 
a laboratory-based infrared source was investigated first 
to discriminate cirrhosis and hepatocellular carcinoma. 
Acquisitions were performed on the same tissue sections 
(Table  1) either using synchrotron radiation or using 
the IR lab-source. Spectroscopic and statistical analysis 
using PCA were investigated on the frequency domains 
1360–1480 and 950–1180  cm−1. As expected, a much 
less variance was observed in the spectra acquired with 
the laboratory-based IR source. However, the discrimi-
nation between cirrhosis and HCC remained possible 
(Fig. 6f–i; Additional file 2: Figure S1). Studies were fur-
ther performed on patients exhibiting dysplastic lesions 
(Tables  1, 2) including the patient #37 that was inves-
tigated by both synchrotron radiation and the IR lab-
source. Interestingly, the dysplastic nodules were still 
discriminated from either benign or cancerous lesions 
(Fig. 7; Additional file 2: Figure S1).
Characterization of quantifiable spectral markers 
for diagnosis of benign, dysplastic and malignant lesions
The possibility of grading hepatocellular nodules in cir-
rhotic livers using laboratory-based infrared microspec-
troscopy opens new avenue for diagnosis. We sought to 
define quantitative markers related to the pathological 
status of the tissue by the calculation of ratio between 
the areas of two bands in the IR spectrum. This approach 
exhibited the advantage to provide values independ-
ent of the conditions of acquisition (e.g. variations in 
the thickness of tissue sections). Spectroscopic analysis 
was undertaken on series of 32 liver surgical specimens 
including 11 normal livers and 21 cirrhotic livers with 
HCC (Table 1). Five ratios were investigated in order to 
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take advantage of complete information contained in the 
IR spectra, which allowed distinguishing normal livers to 
pathological livers. Moreover, four ratios allowed signifi-
cant discrimination between cirrhosis and hepatocellular 
carcinoma. In particular, the three ratios (ratio 1: 1010–
1050/950–1180, ratio 2: 1200–1280/950–1180 and ratio 
3: 1380–1410/1430–1470) calculated in the fingerprint-
ing region of the IR spectrum led to the most significant 
separation of cirrhosis and HCC whatever the alcoholic 
or viral aetiology (Fig. 8).
The study was further performed on tissue samples 
from 7 patients (Table 2) exhibiting low-grade dysplastic 
nodule (LGDN) (n  =  1), high-grade dysplastic nodules 
(HGDN) (n = 5) and early HCC (n = 1) on cirrhotic liv-
ers. Three among these patients disclosed a concomitant 
HCC. The comparison between benign cirrhotic nodules 
and high grade dysplastic nodules using infrared micro-
spectroscopy was focused on the three ratios in the fin-
gerprinting region of the IR spectrum. Interestingly, a 
significant discrimination was observed when comparing 
regenerative cirrhotic nodules with dysplastic nodules. 
Furthermore, it was also possible using any of the three 
ratios to discriminate dysplastic lesions especially HGDN 
from HCC (Fig. 9).
These results demonstrated the high potential of IR 
microspectroscopy as a method for discriminating cir-
rhotic, dysplastic and carcinomatous nodules thus pro-
viding reliable assessment of the pathological status of 
the tissue.
Discussion
This is the first report investigating the morphologi-
cal steps of hepatocarcinogenesis in human by using 
IR microspectroscopy. Profound alterations of the bio-
chemical composition of the pathological liver were high-
lighted by IR microspectroscopy. Indeed, major changes 
were observed in lipids, proteins and sugars strength-
ening the metabolic reprogramming in carcinogenesis 
[34, 35]. The metabolic anomaly originally described 
in cancer cells was the up-regulation of glycolysis [36]. 
The persistent metabolism of glucose to lactate even in 
aerobic condition has been suggested as an adaptation 
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to hypoxia in cancerous lesions. Thus, subsequent cell 
populations with up-regulated glycolysis have a power-
ful growth advantage, which promotes unconstrained 
proliferation and invasion [37–40]. It has been hypoth-
esized that the altered metabolism specific to cancer 
cells arose from mitochondrial defects. With this regard, 
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liver carcinogenesis involves a depletion of cellular mito-
chondrial content that may be related to the repression 
of the cellular program responsible for proliferation of 
mitochondria [41]. However, the metabolic signatures of 
cancer cells are not only passive responses to damaged 
mitochondria but also result from oncogene-directed 
metabolic reprogramming required for supporting mac-
romolecular synthesis and anabolic growth. Indeed, the 
overexpression of the rate-limiting transporter for glu-
cose uptake GLUT1 has been reported in HCC [42] while 
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the gene encoding hexokinase II which catalyzes the 
first reaction of glycolysis converting glucose to glucose-
6-phosphate was shown amplified in hepatoma cells [43]. 
Metabolic alterations in cancer cells do not concern only 
glycolysis but impact also in depth the lipid metabolism 
and the composition of the proteome. De novo lipogen-
esis in mammalian cells depends on mitochondrial cit-
rate production and fatty acid synthase amplification has 
been reported in cancer [35]. Several amino acid precur-
sors are derived from the transamination of mitochon-
drial intermediates. Oxaloacetate can be transaminated 
to produce aspartate which can serve as precursor for 
asparagine and alpha-ketoglutarate can be transaminated 
to produce glutamate, which in turn can be converted 
to proline, arginine and glutamine [35, 44]. Most can-
cers depend on these syntheses rather than exogenous 
supplies. According with all these observations, we have 
demonstrated that IR microspectroscopy allows revealing 
lower amount of sugars (i.e. glycogen), changes in pro-
teins and higher amount of lipids reflecting the metabolic 
changes in glycolysis, protein synthesis and lipogenesis. 
Thus, IR microspectroscopy provides a global picture of 
the metabolic reprogramming that is now considered as a 
hallmark of cancer [45].
Metabolic reprogramming in liver carcinogenesis can 
constitute a signature easily detectable using IR micro-
spectroscopy for histopathologic diagnosis of precancer-
ous and cancerous lesions. Indeed, IR microspectroscopy 
represents the only technique allowing quantitative 
investigations on the global biochemical composition 
in lipids, proteins and sugars in a single experiment. It 
exhibits the major advantage to be compatible with tissue 
sections performed in routine at the hospital without any 
staining or additional sample preparation. As compared 
to gene-expression analysis or proteomics, IR microspec-
troscopy permits in  situ studies of heterogeneous tis-
sues at the cellular level thus combining the advantages 
of conserving the morphology and a remarkable rapidity 
compared to “omics” analyses.
The systematic screening of patients with cirrhosis by 
liver ultrasonography every 6  months leads to the dis-
closure of hepatocellular nodules which do not meet the 
non-invasive diagnosis criteria for HCC, especially when 
they are small around 2  cm. A guided biopsy of these 
nodules has thus to be performed for confirmation of 
HCC [46]. However, the differential diagnosis between 
high grade dysplastic nodule and HCC on these biopsy 
samples remains extremely difficult if not unfeasible and 
the use of IR microspectroscopy would be greatly helpful 
in this context.
Hepatocellular nodules disclosed on cirrhotic livers 
and measuring more than 2 cm are likely to be well differ-
entiated HCC. Four of the 7 premalignant hepatocellular 
nodules in our series were bigger than 2 cm; only one was 
reclassified as early HCC and none of the 3 others dem-
onstrated any morphological nor immunohistochemical 
criteria of HCC. Interestingly, their IR spectral signatures 
were according with these histological observations.
Conclusions
This study positions infrared (IR) microspectroscopy as a 
powerful approach for investigating liver carcinogenesis. 
The metabolic reprograming that occurs in carcinogen-
esis constitutes a signature for the diagnosis of precan-
cerous and cancerous lesions. Further studies on larger 
series of patients will lead to precise the cut off value for 
discriminating high grade dysplastic lesions and early 
HCC. Such investigations will have to be performed on 
paraffin-embedded biopsies that will allow the use of this 
new method as a routine at the hospital.
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